News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed N.V. Announces Pricing of Public Offering of Common Stock

May 6, 2015

Affimed N.V. Announces Proposed Public Offering of Common Stock

May 4, 2015

Affimed Announces Financial Results for Fourth Quarter and Year End 2014

March 25, 2015

Affimed Announces Fourth Quarter and Year End 2014 Financial Results Conference Call

March 18, 2015

Affimed to Present at the 27th Annual ROTH Conference

March 3, 2015

Affimed to Present at the BIO CEO & Investor Conference and at the Leerink Partners Global Healthcare Conference

February 3, 2015

Affimed Appoints Dr. Martin Treder as Chief Scientific Officer

January 20, 2015

Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs

January 7, 2015

Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH

December 8, 2014

Affimed Reports Financial Results for Third Quarter 2014

November 18, 2014

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Events

All

Scientific

Investors

20Nov

Jefferies 2019 London Healthcare Conference

November 20 - 21, 2019 (London, UK)
Presenter: Adi Hoess

09Dec

Antibody Engineering & Therapeutics

December 9 - 13, 2019 (San Diego, USA)
Presenter: Michael Tesar

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.